SUVEN PHARMACEUTICALS
Back to Income Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹300 Cr | ₹41,129 Cr | ₹454 Cr | ₹362 Cr | ₹317 Cr |
What is the latest Consolidated Net Profit of SUVEN PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹300 Cr |
| Mar2024 | ₹41,129 Cr |
| Mar2023 | ₹454 Cr |
| Mar2022 | ₹362 Cr |
| Mar2021 | ₹317 Cr |
How is Consolidated Net Profit of SUVEN PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹300 Cr | -99.27 | |
| Mar2024 | ₹41,129 Cr | 8,963.15 | |
| Mar2023 | ₹454 Cr | 25.24 | |
| Mar2022 | ₹362 Cr | 14.30 | |
| Mar2021 | ₹317 Cr | - | |
Compare Consolidated Net Profit of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹17,393.0 Cr | -8% | 45.9% | -58.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,859.0 Cr | 4.2% | 5.3% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,618.0 Cr | 3.4% | 12.6% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,718.0 Cr | 2.2% | 4.1% | 28% | Stock Analytics | |
| CIPLA | ₹107,722.0 Cr | 2% | 11.5% | -13.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,081.0 Cr | -6.2% | 5.1% | 9.5% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -8% |
45.9% |
-58.6% |
| SENSEX | -0.4% |
7.1% |
-4% |
You may also like the below Video Courses